Kwality Pharmaceuticals Ltd — Important, 28-05-2026: Company Update

Kwality Pharmaceuticals reported record revenue of INR 157.1 Cr for the recent quarter and INR 503 Cr for the full year, a 36% annual growth. Profit after tax for the full year jumped 69% to INR 67 Cr, with margins improving to 13.4%. Operational successes include international audit clearances, global expansion, and a credit rating upgrade. The company improved its cash cycle and recovered significant receivables. Management projects revenue to reach INR 650-700 Cr in the upcoming year and aims for INR 1,000 Cr as a long-term vision, driven by oncology, new hormone facilities, and biosimilars. Investments in R&D and capacity expansion are underway.